Journal of Alzheimer's disease : JADHumansAlzheimer DiseaseMaleFemaleFollow-Up Studies
NeuroEPO plus (NeuralCIM®) in Alzheimer's disease: Post-trial observational follow-up study.
Saily Sosa Pérez, Nelky Urrutia Amable, Carmen Elena Viada González, Patricia Lorenzo-Luaces, Lizet Sánchez Valdés, Tania Crombet Ramos, Kalet León Monzón, Teresita de Jesús Rodríguez Obaya, Leslie Pérez Ruiz
Published: 202510.1177/13872877251386885
Abstract
BackgroundNeuroEPO plus is a recombinant erythropoietin with a sialic acid content like that produced by astrocytes, lacking the hematopoietic activity of conventional erythropoietin.ObjectiveTo evaluate the efficacy and safety of treatment with neur…
Preview only. Read the full abstract at the source